Vitisin A

CAS : 142449-89-6

Ref. 3D-SFA44989

Informations sur le produit

• Nom: Vitisin A
• Synonymes: Vitisin A (Vitis coignetiae), (1S,6R,7S,11bS)-6-[5-[(1E)-2-[(2S,3S)-3-(3,5-Dihydroxyphenyl)-2,3-dihydro-6-hydroxy-2-(4-hydroxyphenyl)-4-benzofuranyl]ethenyl]-2-hydroxyphenyl]-1,6,7,11b-tetrahydro-1,7-bis(4-hydroxyphenyl)benzo[6,7]cyclohepta[1,2,3-cd]benzofuran-4,8,10-triol, Benzo[6,7]cyclohepta[1,2,3-cd]benzofuran-4,8,10-triol, 6-[5-[(1E)-2-[(2S,3S)-3-(3,5-dihydroxyphenyl)-2,3-dihydro-6-hydroxy-2-(4-hydroxyphenyl)-4-benzofuranyl]ethenyl]-2-hydroxyphenyl]-1,6,7,11b-tetrahydro-1,7-bis(4-hydroxyphenyl)-, (1S,6R,7S,11bS)-, Benzo[6,7]cyclohepta[1,2,3-cd]benzofuran-4,8,10-triol, 6-[5-[2-[3-(3,5-dihydroxyphenyl)-2,3-dihydro-6-hydroxy-2-(4-hydroxyphenyl)-4-benzofuranyl]ethenyl]-2-hydroxyphenyl]-1,6,7,11b-tetrahydro-1,7-bis(4-hydroxyphenyl)-

Description

Vitisin A is an analog of nifedipine that has been shown to have potent anticancer properties. It acts as a protein kinase inhibitor and induces apoptosis in cancer cells. Vitisin A has been found in the urine of both Chinese and human patients with tumors, suggesting that it may play a role in cancer treatment. This compound has been shown to inhibit the activity of various kinases involved in cancer cell proliferation and survival. Its ability to induce apoptosis makes it a promising candidate for anticancer therapy, and it may be useful as an adjunct to other inhibitors or chemotherapeutic agents.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 906.9 g/mol
• Formule: C₅₆H₄₂O₁₂
• Degré de pureté: Min. 95%